Hjem
Helga Bergljot Midtbøs bilde
Foto:
Privat

Helga Bergljot Midtbø

Forsker, Senter for forskning på hjertesykdom hos kvinner
  • E-posthelga.midtbo@uib.no
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen

Helga Midtbø er seniorforsker ved Senter for forskning på hjertesykdom hos kvinner https://www.uib.no/kvinnehjerte og lege ved Hjerteavdelingen ved Haukeland Universitetssykehus. 

Hennes forskning fokuserer på hjertesykdom hos pasienter med autoimmune og revmatiske sykdommer. Hun er leder for flere kliniske prosjekter blant pasienter med revmatoid artritt, psoriasis og Sjögrens syndrom. Som forskningsmetode benyttes bildediagnostiske tester som ekkokardiografi, karstivhet og MR. Hun samarbeider med Professor Eva Gerdts i flere prosjekter, blant annet i Helseundersøkelsen i Hordaland - runde 3 (HUSK3) og FATCOR studien. 

Vitenskapelig artikkel
  • Vis forfatter(e) (2022). Trends in the occurrence of ischaemic heart disease over time in rheumatoid arthritis: 1821 patients from 1972 to 2017. Scandinavian Journal of Rheumatology. 10 sider.
  • Vis forfatter(e) (2022). Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area. Open heart. 1-7.
  • Vis forfatter(e) (2022). Persistent cardiac organ damage in surgically and medically treated primary aldosteronism. Journal of Hypertension. 1204-1211.
  • Vis forfatter(e) (2022). Inflammation, sex, blood pressure changes and hypertension in midlife: the Hordaland Health Study. Journal of Human Hypertension. 1-8.
  • Vis forfatter(e) (2022). Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab. International Journal of Immunopathology and Pharmacology. 8 sider.
  • Vis forfatter(e) (2021). Subclinical cardiac organ damage in patients with moderate to severe psoriasis. Journal of Clinical Medicine. 1-10.
  • Vis forfatter(e) (2021). Stage 1 hypertension, sex, and acute coronary syndromes during midlife: the Hordaland Health Study. European Journal of Preventive Cardiology (EJPC). 8 sider.
  • Vis forfatter(e) (2021). Preclinical cardiac disease in women and men with primary aldosteronism. Blood Pressure. 1-8.
  • Vis forfatter(e) (2021). Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis. Open heart. 7 sider.
  • Vis forfatter(e) (2021). Higher Acceleration/Ejection Time Ratio Predicts Impaired Outcome in Aortic Valve Stenosis. Circulation Cardiovascular Imaging.
  • Vis forfatter(e) (2021). Association of myocardial energetic efficiency with circumferential and longitudinal left ventricular myocardial function in subjects with increased body mass index (The fatcor study). Journal of Clinical Medicine. 1-8.
  • Vis forfatter(e) (2020). Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study. Rheumatology. 3700-3708.
  • Vis forfatter(e) (2020). Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland Health Study. Blood Pressure. 267-275.
  • Vis forfatter(e) (2020). Covariables of myocardial function in women and men with increased body mass index. High Blood Pressure & Cardiovascular Prevention. 1-8.
  • Vis forfatter(e) (2020). Concomitant hypertension is associated with abnormal left ventricular geometry and lower systolic myocardial function in overweight participants: the FAT associated CardiOvasculaR dysfunction study. Journal of Hypertension. 1158-1164.
  • Vis forfatter(e) (2019). Impact of obesity on persistent left Ventricular hypertrophy after aortic valve replacement for aortic stenosis. American Journal of Cardiology. 942-947.
  • Vis forfatter(e) (2019). Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis. International Journal of Cardiology. 1-5.
  • Vis forfatter(e) (2019). Impact of aortic stiffness on myocardial ischaemia in non-obstructive coronary artery disease. Open heart. 1-7.
  • Vis forfatter(e) (2019). Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis. Heart. 1-6.
  • Vis forfatter(e) (2019). Effect of fitness on cardiac structure and function in overweight and obesity (the FATCOR study). NMCD. Nutrition Metabolism and Cardiovascular Diseases. 710-717.
  • Vis forfatter(e) (2018). Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study). NMCD. Nutrition Metabolism and Cardiovascular Diseases. 1054-1060.
  • Vis forfatter(e) (2018). Left Ventricular Systolic Myocardial Function in Ankylosing Spondylitis . Arthritis care & research. 1276-1283.
  • Vis forfatter(e) (2018). Ankylosing spondylitis is associated with increased prevalence of left ventricular hypertrophy. Journal of Rheumatology. 1249-1255.
  • Vis forfatter(e) (2017). Masked hypertension in obesity: Potential predictors and arterial damage. Blood Pressure Monitoring. 12-17.
  • Vis forfatter(e) (2017). Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis. Heart. 1619-1624.
  • Vis forfatter(e) (2017). Does fitness improve the cardiovascular risk profile in obese subjects? NMCD. Nutrition Metabolism and Cardiovascular Diseases. 518-524.
  • Vis forfatter(e) (2016). The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis. Blood Pressure. 298-304.
  • Vis forfatter(e) (2016). Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy: the LIFE study. Blood Pressure. 150-155.
  • Vis forfatter(e) (2016). Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 371-376.
  • Vis forfatter(e) (2015). Disease activity and left ventricular structure in patients with rheumatoid arthritis. Rheumatology. 511-519.
  • Vis forfatter(e) (2005). Trenger pasienter med ventrikkelseptumdefekt endokardittprofylakse? Tidsskrift for Den norske legeforening. 3256-3258.
Leder
  • Vis forfatter(e) (2022). Sex disparities in blood pressure development: Time for action. European Journal of Preventive Cardiology (EJPC). 178-179.
Short communication
  • Vis forfatter(e) (2022). Hjertesykdom er vanlig – også hos kvinner. Tidsskrift for Den norske legeforening. 1-3.
Brev til redaktøren
  • Vis forfatter(e) (2021). Response to 'Letter to the Editor' by Rognstad et al. European Journal of Preventive Cardiology (EJPC).
  • Vis forfatter(e) (2016). Response to: 'Disease activity and left ventricular systolic function in rheumatoid arthritis' by Giollo et al. Annals of the Rheumatic Diseases. e84-e84.
Doktorgradsavhandling
  • Vis forfatter(e) (2016). Subclinical cardiovascular disease in patients with rheumatoid arthritis. Relation to disease activity and cardiovascular risk factors.
Sammendrag/abstract
  • Vis forfatter(e) (2022). SEX DIFFERENCES IN ARTERIAL FUNCTION IN OBESITY: THE FAT-ASSOCIATED CARDIOVASCULAR DYSFUNCTION STUDY. Journal of Hypertension. e270-e270.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2020). How reproducible is the diagnosis of borderline rheumatic heart disease? . International Journal of Cardiology.
  • Vis forfatter(e) (2016). Atherosclerosis in Sjögren's syndrome: Evidence, possible mechanisms and knowledge gaps. Clinical and Experimental Rheumatology. 133-142.
Nettsider (opplysningsmateriale)
  • Vis forfatter(e) (2013). Leddgikt kan øke risikoen for hjerte- og karsykdom.
Fagartikkel
  • Vis forfatter(e) (2020). Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy. Case Reports in Anesthesiology. 5 sider.

Se fullstendig oversikt over publikasjoner i CRIStin.

Vitenskapelige publikasjoner

  1. Bahlmann E, Einarsen E, Cramariuc D, Midtbø H, Mancusi C, Rossebø AB, Willems S, Gerdts E. Low myocardial energetic efficiency is associated with increased mortality in asymptomatic aortic valve stenosis. Open Heart 2021.
  2. Midtbø H, Gerdts E. Sex disparities in blood pressure development: time for action. Eur J Prev Cardiol 2021.
  3. Linde A, Gerdts E, Tveit KS, Kringeland E, Midbø H. Subclinical cardiac organ damage in patients with moderate to severe psoriasis. J Clin Med May 2021.
  4. Kringeland E, Tell GS, Midtbø H, Igland J, Haugsgjerd T, Gerdts E. Stage 1 hypertension is a stronger risk factor for acute coronary syndromes in women than in men: The Hordaland Health Study. In press Eur J Prev Cardiol 2021.
  5. Mancusi C, Midtbø H, De Luca N, Halland H, de Simone G, Gerdts E. Association of Myocardial Energetic Efficiency with Circumferential and Longitudinal Left Ventricular Myocardial Function in Subjects with Increased Body Mass Index (the FATCOR Study). J Clin Med 2021.
  6. Aune A, Kokorina M, Grytaas M, Midtbø H, Løvås K, Gerdts E. Preclinical cardiac disease in women and men with primary aldosteronism. Blood Pressure 2021.
  7. Midtbø H, Hauge SW, Haaverstad R, Dalen H. How reproducible is the diagnosis of borderline rheumatic heart disease? Int J Cardiol. Dec 2020.
  8. Einarsen E, Cramariuc D, Bahlmann E, Midtbø H, Chambers J, Gerdts E. Higher acceleration ejection time ratio predicts impaired outcome in non-severe aortic valve stenosis. Circulation: Cardiovascular Imaging 2021.
  9. Vo AK, Reikvam H, Midtbø H, Wirsching JL, Bruserud Ø, Wendelbo Ø. Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy. Case Rep Anesthesiol Oct 2020.
  10. Pristaj N, Saeed S, Midtbø H, Halland H, Matre K, Gerdts E. Sex-specific Covariables of Myocardial Function in Subjects with Increased Body Mass Index. High Blood Press Cardiovasc Prev 2020.
  11. Kringeland E, Tell GS, Midtbø H, Haugsgjerd TR, Igland J, Gerdts E. Factors associated with increase in blood pressure and incident hypertension in early midlife: the Hordaland Health Study. Blood Press 2020;13: 1-9.
  12. Os HA, Rollefstad S, Gerdts E, Kringeland E, Ikdahl E, Semb AG, Midtbø H. Preclinical cardiac organ damage during statin treatment in patients with inflammatory joint diseases: the RORA-AS statin intervention study. Rheumatology Dec 2020.
  13. Herfindal B, Gerdts E, Kringeland EA, Saeed S, Midtbø H, Halland H. Concomitant hypertension is associated with abnormal left ventricular geometry and lower systolic myocardial function in overweight participants: the FAT associated CardiOvasculaR dysfunction study. J Hypertens. 2020: 38:1158-1164.
  14. Losi MA, Mancusi C, Midtbø H, Saeed S, de Simone G, Gerdts E. Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis. Int J Cardiol. 2019 Oct 3.
  15. Midtbø H, Semb AG, Matre K, Rollefstad S, Berg IJ, Jonsson R, Gerdts E. Left ventricular systolic myocardial function in ankylosing spondylitis. Arthritis Care Research 2019; 71: 1276-83.
  16. Lønnebakken MT, Eskerud I, Larsen TH, Midtbø H, Kokorina MV, Gerdts E. Impact of aortic stiffness on myocardial ischemia in non-obstructive coronary artery disease. Open Heart. 2019 May 4.
  17. Gerdts E, Saeed S, Midtbø H, Rossebø A, Chambers JB, Einarsens E, Bahlmann E, Devereux R. Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis. Heart. 2019; 105:1629-33.
  18. Halland H, Matre K, Einarsen E, Midtbø H, Saeed S, Pristaj N, Lønnebakken MT, Gerdts E. Effect of fitness on left ventricular systolic myocardial function in overweight and obesity. Nutr Metab Cardiovasc Dis 2019; 29: 710-17.
  19. Einarsen E, Saeed S, Vramariuc D, Chambers JB, Midtbø H, Gerdts E. Impact of Obesity on Persistent Left Ventricular Hypertrophy After Aortic Stenosis Valve Replacement for Aortic Stenosis. Am J Cardiol 2019; 15: 942-47.
  20. Halland H, Lønnebakken MT, Pristaj N, Saeed S, Midtbø H, Einarsen E, Gerdts E. Sex differences in overweight and obesity. Nutr Metab Cardiovasc Dis 2018; 28: 1054-60.
  21. Midtbø H, Gerdts E, Berg IJ, Rollefstad S, Jonsson R, Semb AG. Ankylosing spondylitis is associated with increased prevalence of left ventricular hypertrophy. The Journal of Rheumatology 2018 ; 45: 1249-55.
  22. Thomassen H, Giovanni C, Gerdts E, Einarsen E, Midtbø H, Cramariuc D. Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis. Heart 2017;103:1619- 24.
  23. Midtbø H, Semb AG, Matre K, Kvien TK, Gerdts E. Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis. Ann Rheum Dis 2017; 76:371-376.
  24. Halland H, Lønnebakken MT, Saeed S, Midtbø H, Cramariuc D, Gerdts E. Does fitness improve cardiovascular risk profile in obese subjects? Nutr Metab Cardiovasc Dis 2017; 27:518-24.
  25. Kenny IE, Saeed S, Lønnebakken MT, Midtbø H, Halland H, Gerdts E. Prevalence and covariates of masked hypertension in obese subjects. Blood Pressure Monitoring. 2017; 22: 12-17.
  26. Mancusi C, Gerdts E, de Simone G, Midtbø H, Lønnebakken MT, Boman K, Wachtell K, Dahlöf B, Devereux RB. Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patient with left ventricular hypertrophy (the LIFE study). Blood Pressure 2016; 26: 150-55.
  27. Midtbø H, Gerdts E, Kvien TK, Olsen IC, Lønnebakken MT, Davidsen ES, et al. The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis. Blood Press 2016; 25: 298-04.
  28. Valim V, Gerdts E, Jonsson R, Ferreira GA, Brokstad KA, Brun JG, Midtbø H, et al. Atherosclerosis in Sjogren's syndrome: evidence, possible mechanisms and knowledge gaps. Clin Exp Rheumatol 2016;34:133-42.
  29. Midtbø H, Gerdts E, Kvien TK, Olsen IC, Hirth A, Davidsen ES, et al. Disease activity and left ventricular structure in patients with rheumatoid arthritis. Rheumatology (Oxford) 2015; 54:511-9.
  30. Midtbø H, Hirth A, Norgård G, Greve G. Do patients with ventricular septal defect need endocarditits prophylaxis?. Tidsskr Nor Laegeforen 2005; 25:3256-8.

 

  • JointHeart Kan immunmodulerende behandling reversere preklinisk hjerteskade blant pasienter med revmatoid artitt? Samarbeidsprosjekt mellom Revmatologisk avdeling, Radiologisk avdeling, Bevital og Laboratorieklinikken ved Haukeland Universitetssykehus
  • Hjertefunksjon ved psoriasis Har pasienter med psoriasis økt forekomst av preklinisk hjerteskade? Samarbeidsprosjekt med Hudavdelingen ved Haukeland Universitetssykehus og Bevital AS.
  • Preklinisk hjerteskade ved primært Sjögrens syndrom Samarbeidsprosjekt med Professor Valéria Valim ved Universidade Federal do Espirito Santo, Brazil

Twitter